Become an
Expert in Spirometry

Per cent predicted is misleading

Distribution of residual of FEV1 versus standing height

The percentage of publications that do not use ‘per cent predicted’ for spirometric indices, is negligible. This is because this usage is copied unthinkingly; in spite of its widespread adoption per cent predicted is not scientifically founded (see ref. 1), unless in children and adolescents. Similarly it is inappropriate to express a change in spirometric indices, for example due to an intervention such as bronchodilatation, as a percentage of the initial value. The indiscriminate use of 80% of predicted as the ‘lower limit of normal’ cannot be justified at all.

Distribution of residual of FEV1 versus ageWhen is ‘% predicted value’ correct? Simply, when the scatter is proportional to the predicted value. In other words, if in a reference group a low predicted value is associated with a small scatter, and a high predicted value associated with a proportionally larger scatter. The left upper diagram illustrates the relationship between residual scatter in FEV1 and standing height in asymptomatic lifelong non-smoking males. The figure also shows the regression line and the 95% confidence interval for predicted values in individuals. There is no sign whatsoever that the scatter is small in short persons (with a low FEV1), and high in tall subjects (high FEV1); the same lack of trend is observed if the residual scatter in FEV1 is plotted as a function of age. This corroborates what we saw earlier in females, in whom the scatter was similarly independent of age (see ref. 2).

See also:
Bias due to percent predicted in adults
Scatter independent of level

 
Ref. 1 - Do not use per cent predicted in adults
1 Sobol BJ. Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility. Thorax 1966; 21: 445-449.
2 Oldham PD. Percent of predicted as the limit of normal in pulmonary function testing: a statistically valid approach. Thorax 1979; 34: 569.
3 Miller A. Prediction equations and ‘normal values’. In: Miller A, ed. Pulmonary function tests in clinical and occupational lung disease. New York, Grune & Stratton, 1986; 197-213.
4 Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988; 43: 265-267.
5 Quanjer PhH. Predicted values: how should we use them (letter). Thorax 1988; 43: 663-664.
6 ATS Statement. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
7 Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6 suppl. 16: 5-40.
 
Ref. 2 - Constant scatter about predicted in adults
1 Drouet D, Kauffmann F, Brille D, Lellouch J. Valeurs spirographiques de référence. Modèles mathématiques et utilisation pratique. Bull Europ Physiopath Resp 1980; 16: 745-767.
2 Glindmeyer HW, Lefante JJ, McColloster C, Jones RN, Weill H. Blue-collar normative spirometric values for Causasian and African-American men and women aged 18 to 65. Am J Respir Crit Care Med 1995; 151: 412-423.
Top of page | | | ©Philip H. Quanjer